Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex

Tralokinumab, a fully human mAb specifically targeting the IL-13 cytokine, has demonstrated clinical efficacy and safety in patients with moderate-to-severe atopic dermatitis. Tralokinumab binds IL-13 with high affinity, which prevents the interaction of IL-13 with IL-13Rα1 and subsequent signaling....

全面介绍

Saved in:
书目详细资料
Main Authors: Maxim A.X. Tollenaere (Author), Christina Mølck (Author), Ian Henderson (Author), Scott Pollack (Author), Philip Addis (Author), Helle Heibroch Petersen (Author), Hanne Norsgaard (Author)
格式: 图书
出版: Elsevier, 2023-09-01T00:00:00Z.
主题:
在线阅读:Connect to this object online.
标签: 添加标签
没有标签, 成为第一个标记此记录!

因特网

Connect to this object online.

3rd Floor Main Library

持有资料详情 3rd Floor Main Library
索引号: A1234.567
复印件 1 可用